EE04941B1 - Ravimid skisofreenia ennetamiseks ja raviks ning nende valmistamine - Google Patents

Ravimid skisofreenia ennetamiseks ja raviks ning nende valmistamine

Info

Publication number
EE04941B1
EE04941B1 EEP200200698A EEP200200698A EE04941B1 EE 04941 B1 EE04941 B1 EE 04941B1 EE P200200698 A EEP200200698 A EE P200200698A EE P200200698 A EEP200200698 A EE P200200698A EE 04941 B1 EE04941 B1 EE 04941B1
Authority
EE
Estonia
Prior art keywords
schizophrenia
medicines
prevention
preparation
treatment
Prior art date
Application number
EEP200200698A
Other languages
English (en)
Inventor
Furukawa Kiyoshi
Kurumiya Satoshi
Okimoto Kazuo
Ohno Kazunori
Original Assignee
Dainippon Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co., Ltd. filed Critical Dainippon Pharmaceutical Co., Ltd.
Publication of EE200200698A publication Critical patent/EE200200698A/et
Publication of EE04941B1 publication Critical patent/EE04941B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines having two or more nitrogen atoms in the same ring, e.g. oxadiazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
EEP200200698A 2000-06-21 2001-06-12 Ravimid skisofreenia ennetamiseks ja raviks ning nende valmistamine EE04941B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000185814 2000-06-21
PCT/JP2001/004934 WO2001098300A1 (fr) 2000-06-21 2001-06-12 Medicaments utilises dans la prevention et le traitement de maladies neurodegeneratives

Publications (2)

Publication Number Publication Date
EE200200698A EE200200698A (et) 2004-08-16
EE04941B1 true EE04941B1 (et) 2007-12-17

Family

ID=18686074

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200698A EE04941B1 (et) 2000-06-21 2001-06-12 Ravimid skisofreenia ennetamiseks ja raviks ning nende valmistamine

Country Status (19)

Country Link
US (1) US6743803B2 (et)
EP (1) EP1295883A4 (et)
KR (1) KR20030010740A (et)
CN (1) CN100354274C (et)
AU (2) AU6274101A (et)
BR (1) BR0111799A (et)
CA (1) CA2412199A1 (et)
CZ (1) CZ20024153A3 (et)
EE (1) EE04941B1 (et)
HU (1) HUP0301319A3 (et)
IL (2) IL153439A0 (et)
MX (1) MXPA02012599A (et)
NO (1) NO20026148L (et)
NZ (1) NZ523189A (et)
PL (1) PL200537B1 (et)
RU (1) RU2258506C2 (et)
SK (1) SK17682002A3 (et)
TW (1) TWI298068B (et)
WO (1) WO2001098300A1 (et)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6822097B1 (en) 2002-02-07 2004-11-23 Amgen, Inc. Compounds and methods of uses
TW200533371A (en) * 2004-04-15 2005-10-16 Dainippon Pharmaceutical Co Medicament comprising a combination of an acetylcholinesterase inhibitor and a 5-substituted-3-oxadiazolyl-1,6-naphthyridin-2(1h)-one derivative
EP1595881A1 (en) * 2004-05-12 2005-11-16 Pfizer Limited Tetrahydronaphthyridine derivates useful as histamine H3 receptor ligands
WO2010002451A1 (en) * 2008-07-01 2010-01-07 Concert Pharmaceuticals, Inc. Naphthyridin derivatives
JP6551671B2 (ja) * 2015-08-11 2019-07-31 国立大学法人 熊本大学 アルツハイマー治療薬
JP2022541554A (ja) * 2019-07-18 2022-09-26 アバクシス セラピューティクス １，２，４－オキサジアゾール誘導体の固体製剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2683818B1 (fr) 1991-11-14 1993-12-31 Adir Cie Nouveaux derives de 3-sulfonylamino-2-(1h)-quinoleinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
JPH09291034A (ja) 1996-02-27 1997-11-11 Yoshitomi Pharmaceut Ind Ltd 縮合ピリジン化合物およびその医薬としての用途
TW486479B (en) * 1997-07-15 2002-05-11 Dainippon Pharmaceutical Co 5-substituted-3-oxadiazolyl-1,6-naphthyridin-2(1H)-one derivatives
AR013184A1 (es) * 1997-07-18 2000-12-13 Astrazeneca Ab Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis
DE60022050C5 (de) 1999-06-02 2007-10-11 NPS Pharmaceuticals, Inc., Salt Lake City Metabotrope glutamatrezeptorantagonisten zur behandlung von krankheiten des zentralen nervensystems

Also Published As

Publication number Publication date
SK17682002A3 (sk) 2003-08-05
CN1447809A (zh) 2003-10-08
US6743803B2 (en) 2004-06-01
RU2258506C2 (ru) 2005-08-20
NO20026148D0 (no) 2002-12-20
KR20030010740A (ko) 2003-02-05
CZ20024153A3 (cs) 2003-06-18
AU6274101A (en) 2002-01-02
PL363869A1 (en) 2004-11-29
EP1295883A1 (en) 2003-03-26
NZ523189A (en) 2004-08-27
PL200537B1 (pl) 2009-01-30
HUP0301319A3 (en) 2008-06-30
MXPA02012599A (es) 2003-05-14
WO2001098300A1 (fr) 2001-12-27
US20030166673A1 (en) 2003-09-04
NO20026148L (no) 2003-02-20
CA2412199A1 (en) 2001-12-27
EP1295883A4 (en) 2003-06-11
TWI298068B (en) 2008-06-21
IL153439A0 (en) 2003-07-06
CN100354274C (zh) 2007-12-12
EE200200698A (et) 2004-08-16
HUP0301319A2 (hu) 2003-09-29
AU2001262741B2 (en) 2005-07-07
BR0111799A (pt) 2003-05-27
IL153439A (en) 2007-07-24

Similar Documents

Publication Publication Date Title
DE60121992D1 (de) Zusammensetzung zur verabreichung und beschichtung medizinischer geräte
IL196301A0 (en) Medicament for the treatment of hapatitis c
EP1399171A4 (en) MEDICINAL HERB COMPOUNDS FOR THE PREVENTION AND TREATMENT OF DIABETES
DE60126321D1 (de) Gelsystem zur ocularen verabreichung von arzneimitteln
NO20006630L (no) Farmasöytisk sammensetning for behandlingen av diabetes
DE60239648D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung von Asthma
EE200200628A (et) Dihüdroksüestrite ja nende derivaatide valmistamismeetod
ATE384522T1 (de) Medikamente zur chemotherapeutischen behandlung von erkrankungen
EE05020B1 (et) Glburiidi ravimkoostis
EE200200717A (et) Ravimpreparaat ängistusneuroosi või depressiooni raviks ja piperasiiniderivaadid
EE200200271A (et) Ravimkombinatsioonid ning nende kasutamine
NO20023482D0 (no) Fremgangsmåte for behandling av stoffmisbruk
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
GB0004531D0 (en) The treatment of respiratory diseases
NO20026219L (no) Forbindelser for behandling av svekket fundisk relaksasjon
DE60016047D1 (de) Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten
FI20001985A (fi) Laitteisto ja menetelmä palautuspullojen käsittelyssä
EE04941B1 (et) Ravimid skisofreenia ennetamiseks ja raviks ning nende valmistamine
PT1152756E (pt) Derivados de anticonvulsivo uteis no tratamento do autismo
NO20020784L (no) Medikament for behandling av brudd
AU2002325169A1 (en) Pharmaceutical composition for the prophylaxis and/or treatment of virus diseases
EE200300057A (et) Koostis vähi profülaktikaks ja raviks
IL137275A0 (en) Pharmaceutical composition for the treatment of anal fissures
ATE314064T1 (de) L-acetylcarnitin und l-propionylcarnitin zusammensetzung zur verhütung und behandlung von nierenstörungen und nierenenkrankheit
FR2800614B1 (fr) Composition pour le traitement des infections des voies respiratoires

Legal Events

Date Code Title Description
GB1A Change in the ownership or in the address of the owner
KB4A Valid patent at the end of a year

Effective date: 20081231

MM4A Lapsed by not paying the annual fees

Effective date: 20090612